1. Home
  2. VYX vs MDXG Comparison

VYX vs MDXG Comparison

Compare VYX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$6.71

Market Cap

980.9M

Sector

N/A

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.57

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
MDXG
Founded
1881
2006
Country
United States
United States
Employees
13500
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.9M
530.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
VYX
MDXG
Price
$6.71
$3.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
$13.67
$9.00
AVG Volume (30 Days)
2.1M
1.9M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$418,630,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.99
52 Week Low
$6.02
$3.03
52 Week High
$14.67
$7.99

Technical Indicators

Market Signals
Indicator
VYX
MDXG
Relative Strength Index (RSI) 43.19 47.00
Support Level $6.54 $3.11
Resistance Level $7.26 $7.39
Average True Range (ATR) 0.40 0.16
MACD -0.05 0.04
Stochastic Oscillator 2.29 78.01

Price Performance

Historical Comparison
VYX
MDXG

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: